Introduction of photodynamic therapy for the treatment of neovascular age-related macular degeneration: tracking a moving target

被引：0
|
作者：
B Foot
R Foy
U Chakravarthy
R Wormald
机构：
[1] The Royal College of Ophthalmologists,Research and Development Department
[2] Moorfields Eye Hospital,Department of Reproductive and Development Sciences
[3] University of Edinburgh,undefined
来源：
Eye | 2003年 / 17卷
关键词：
photodynamic therapy; service provision; health technology;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Objectives To identify changes in referral and treatment patterns of neovascular age-related macular degeneration with photodynamic therapy (PDT) within ophthalmology units in NHS hospitals and assess how beliefs about what would constitute a worthwhile level of clinical benefit had altered over a 12-month period.
引用
收藏
页码：583 / 586
页数：3
相关论文
共 50 条
  • [21] Pegaptanib Versus Combined Pegaptanib and Photodynamic Therapy for Neovascular Age-Related Macular Degeneration
    Akduman, Levent
    Kaderli, Berkant
    Kim, Max
    Brusatti, Robert
    Jones, Michael
    TURKIYE KLINIKLERI TIP BILIMLERI DERGISI, 2010, 30 (03): : 978 - 984
  • [22] Photodynamic therapy with verteporfin is effective for selected patients with neovascular age-related macular degeneration
    Fine, SL
    ARCHIVES OF OPHTHALMOLOGY, 1999, 117 (10) : 1400 - 1402
  • [23] Intravitreal bevacizumab vs verteporfin photodynamic therapy for Neovascular age-related macular degeneration
    Bashshur, Ziad F.
    Schakal, Alexandre
    Hamam, Rola N.
    El Haibi, Christelle P.
    Jaafar, Rola F.
    Noureddin, Baha' N.
    ARCHIVES OF OPHTHALMOLOGY, 2007, 125 (10) : 1357 - 1361
  • [24] Verteporfin Photodynamic Therapy Combined With Intravitreal Bevacizumab for Neovascular Age-Related Macular Degeneration
    Kaiser, Peter K.
    OPHTHALMOLOGY, 2009, 116 (04) : 747 - 755
  • [25] Radiation Therapy for Neovascular Age-related Macular Degeneration
    Kishan, Amar U.
    Modjtahedi, Bobeck S.
    Morse, Lawrence S.
    Lee, Percy
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 85 (03): : 583 - 597
  • [26] Guidance for the treatment of neovascular age-related macular degeneration
    Schmidt-Erfurth, Ursula M.
    Richard, Gisbert
    Augustin, Albert
    Aylward, William G.
    Bandello, Francesco
    Corcostegui, Borja
    Cunha-Vaz, Jose
    Gaudric, Alain
    Leys, Anita
    Schlingemann, Rainier O.
    ACTA OPHTHALMOLOGICA SCANDINAVICA, 2007, 85 (05): : 486 - 494
  • [27] Bevacizumab for the Treatment of Neovascular Age-Related Macular Degeneration
    Pitlick, Jamie M.
    Vecera, Kayla F.
    Barnes, Kylie N.
    Reski, John W.
    Forinash, Alicia B.
    ANNALS OF PHARMACOTHERAPY, 2012, 46 (02) : 290 - 296
  • [28] TREATMENT PATTERNS OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Dugel, P. U.
    Arnold, R. J.
    Layton, A. J.
    VALUE IN HEALTH, 2014, 17 (03) : A149 - A149
  • [29] AFLIBERCEPT FOR THE TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Verner-Cole, E. A.
    Davis, S. J.
    Lauer, A. K.
    DRUGS OF TODAY, 2012, 48 (05) : 317 - 329
  • [30] Advances in the treatment of neovascular age-related macular degeneration
    Lanzetta, Paolo
    EJHP PRACTICE, 2008, 14 (06): : 17 - 20
12345